Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications

Internal Medicine
Ken IkedaYasuo Iwasaki

Abstract

Parkinson disease (PD) is a slowly progressive neurodegenerative disease characterized by the loss of dopaminergic neurons and terminals in the nigrostriatal system. Dopamine transporter (DAT) imaging is widely performed for the differential diagnosis of PD and other degenerative parkinsonism from essential tremor, vascular parkinsonism, and drug-induced parkinsonism. DAT is the plasma membrane carrier specific to dopamine neurons that are responsible for re-uptaking dopamine from the synaptic cleft back into the nerve ending. DAT binding might reflect striatal presynaptic dysfunction or DAT expression in PD patients. Longitudinal studies of DAT imaging have reported progressive changes from early PD patients. This imaging may be used as a progressive biomarker. Follow-up DAT imaging for therapeutic interventions has been applied for several anti-parkinsonian drugs. We herein review the progressive changes and therapeutic modification of DAT binding by anti-PD medications in early PD patients.

References

Jun 9, 1987·Brain Research·C L Schauf
Jun 1, 1996·Seizure : the Journal of the British Epilepsy Association·M KitoK Watanabe
May 29, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·R B InnisJ P Seibyl
Dec 10, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·J E AhlskogO L Burnett
Nov 10, 2000·Journal of Neural Transmission·W StaffenG Ladurner
Jan 5, 2002·Neuroscience Research·M MurataI Kanazawa
Apr 3, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN Parkinson Study Group
Feb 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·A WinogrodzkaE C Wolters
Nov 26, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Walter PirkerThomas Brücke
Dec 14, 2004·The New England Journal of Medicine·Stanley FahnUNKNOWN Parkinson Study Group
Jan 4, 2007·Neurology·Miho MurataUNKNOWN Japan Zonisamide on PD Study Group
May 2, 2007·Brain : a Journal of Neurology·Chaorui HuangDavid Eidelberg
Apr 25, 2014·Neurology·Kenneth MarekUNKNOWN Parkinson Study Group PRECEPT Investigators
Jul 23, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Julia KraemmerWalter Pirker

❮ Previous
Next ❯

Citations

Aug 14, 2019·Cells·Giovanni Palermo, Roberto Ceravolo
Feb 14, 2020·International Journal of Molecular Sciences·Ewelina PalaszGrazyna Niewiadomska
Aug 29, 2020·Brain : a Journal of Neurology·Emma BiondettiStéphane Lehéricy
Dec 5, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Dario ArnaldiFlavio Nobili
May 7, 2020·Asian Journal of Pharmaceutical Sciences·Chengliang HuLigong Chen
Mar 23, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Rahul GauravStéphane Lehéricy
Apr 6, 2021·Frontiers in Neuroscience·Yasuo TeraoMasahiko Suzuki
Apr 6, 2021·Journal of Movement Disorders·Dinkar KulshreshthaMandar Jog
Jun 10, 2021·Medicinal Research Reviews·Ramón CacabelosJuan C Carril
Sep 18, 2021·Journal of Neurochemistry·Natasha S R BidesiMatthias M Herth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
G KägiEduardo Tolosa
Movement Disorders : Official Journal of the Movement Disorder Society
Christoph ScherflerWerner Poewe
Parkinsonism & Related Disorders
Suja Sadasivan, Joseph H Friedman
Movement Disorders : Official Journal of the Movement Disorder Society
Francesco RoselliGiuseppe Rubini
© 2022 Meta ULC. All rights reserved